Skip to content

Change in AP at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$2.71M+226%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
-$652K+33.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$4.99M-77.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$7.17M-141%
LQD
Liquidia CorporationLQDA
$562K-83.6%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-$5.62M-54.6%

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.58B+128%

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0.0×
Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's change in AP?
Kiniksa Pharmaceuticals International, plc (KNSA) reported change in AP of $22.27M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's change in AP changed year-over-year?
Kiniksa Pharmaceuticals International, plc's change in AP increased by 35812.9% year-over-year, from $62K to $22.27M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.